{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T15:14:57Z","timestamp":1790090097946,"version":"4.0.1"},"reference-count":22,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,2,13]],"date-time":"2014-02-13T00:00:00Z","timestamp":1392249600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":["journalofclinicalvirology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Virology"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1016\/j.jcv.2014.02.002","type":"journal-article","created":{"date-parts":[[2014,2,14]],"date-time":"2014-02-14T12:03:14Z","timestamp":1392379394000},"page":"44-49","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"title":["Individual detection of 14 high risk human papilloma virus genotypes by the PapType test for the prediction of high grade cervical lesions"],"prefix":"10.1016","volume":"60","author":[{"given":"Jack","family":"Cuzick","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Terry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Kleeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Giddings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet","family":"Austin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Cadman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lesley","family":"Ashdown-Barr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria J.","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Szarewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcv.2014.02.002_bib0005","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S1470-2045(09)70096-8","article-title":"Special report, policy. A review of human carcinogens. Part B","volume":"10","author":"Bouvard","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jcv.2014.02.002_bib0010","volume":"vol. 100B","author":"IARC","year":"2009"},{"key":"10.1016\/j.jcv.2014.02.002_bib0015","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1136\/jcp.57.1.68","article-title":"Multiple high risk HPV infections are common in cervical neoplasia and young women in a cervical screening population","volume":"57","author":"Cuschieri","year":"2004","journal-title":"J Clin Path"},{"key":"10.1016\/j.jcv.2014.02.002_bib0020","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1128\/JCM.02438-06","article-title":"Comparison of the Digene Hybrid Capture 2 assay and Roche AMPLICOR and LINEAR ARRAY human papillomavirus (HPV) tests in detecting high-risk HPV genotypes in specimens from women with previous abnormal pap smear results","volume":"45","author":"Stevens","year":"2007","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jcv.2014.02.002_bib0025","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1158\/1055-9965.EPI-08-0508","article-title":"Comparison of predictors for high grade cervical intraepithelial neoplasia in women with abnormal smears","volume":"17","author":"Szarewski","year":"2008","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.jcv.2014.02.002_bib0030","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/S1470-2045(11)70188-7","article-title":"Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older, a subanalysis of the ATHENA study","volume":"12","author":"Castle","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.jcv.2014.02.002_bib0035","doi-asserted-by":"crossref","first-page":"3980","DOI":"10.1128\/JCM.00516-11","article-title":"Comparison of the INNO-LiPA and PapType assays for detection of human papillomavirus in archival vulva dysplasia and\/or neoplasia tissue biopsy specimens","volume":"49","author":"Tan","year":"2011","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jcv.2014.02.002_bib0040","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.1128\/JCM.01064-12","article-title":"Comparison of PapType to Digene Hybrid Capture, Roche Linear Array and Amplicor for detection of high risk human papillomavirus genotypes in women with previous abnormal pap smears","volume":"50","author":"Tabrizi","year":"2012","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jcv.2014.02.002_bib0045","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1128\/JCM.00181-12","article-title":"A comparison of seven tests for high grade cervical intraepithelial neoplasia in women with abnormal smears, the Predictors 2 study","volume":"50","author":"Szarewski","year":"2012","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jcv.2014.02.002_bib0050","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1002\/ijc.27713","article-title":"Differences in human papillomavirus type distribution in high-grade cervical intraepithelial neoplasia an invasive cancer in Europe","volume":"132","author":"Tjalma","year":"2013","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jcv.2014.02.002_bib0055","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1309\/AJCPYB6C4HIMLZIX","article-title":"Don\u2019t forget HPV-45 in cervical cancer screening","volume":"137","author":"Tjalma","year":"2012","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.jcv.2014.02.002_bib0060","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/S1470-2045(10)70230-8","article-title":"Human papillomavirus genotype attribution in invasive cervical cancer, a retrospective cross-sectional worldwide study","volume":"11","author":"Sanjose","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.jcv.2014.02.002_bib0065","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/ijc.27608","article-title":"A population-based study of human papillomavirus genotype prevalence in the United States: baseline measures prior to mass papillomavirus vaccination","volume":"132","author":"Wheeler","year":"2012","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jcv.2014.02.002_bib0070","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/ijc.21210","article-title":"Prevalence of types 16 and 33 is increased in high-risk human papillomavirus positive women with cervical intraepithelial neoplasia grade 2 or worse","volume":"117","author":"Bulkmans","year":"2005","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jcv.2014.02.002_bib0075","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/sj.bjc.6603843","article-title":"HPV type-specific risks of high-grade CIN during 4 years of follow-up: a population-based prospective study","volume":"97","author":"Naucler","year":"2007","journal-title":"BJC"},{"key":"10.1016\/j.jcv.2014.02.002_bib0080","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1093\/jnci\/djn510","article-title":"Human papillomavirus genotype distributions, Implications for vaccination and cancer screening in the United States","volume":"101","author":"Wheeler","year":"2009","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.jcv.2014.02.002_bib0085","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1158\/1055-9965.EPI-10-0791","article-title":"Incident cervical HPV infections in young women: transition probabilities for CIN and infection clearance","volume":"20","author":"Insinga","year":"2011","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.jcv.2014.02.002_bib0090","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1093\/jnci\/djr283","article-title":"Persistence of type-specific Human Papilloma virus infection and increased long-term risk of cervical cancer","volume":"103","author":"Chen","year":"2012","journal-title":"JNCI"},{"key":"10.1016\/j.jcv.2014.02.002_bib0095","doi-asserted-by":"crossref","DOI":"10.1158\/1055-9965.EPI-11-0206","article-title":"A long-term prospective study of type-specific human papillomavirus infection and risk of cervical neoplasia among 20,000 women in the Portland Kaiser cohort study","volume":"20","author":"Schiffman","year":"2011","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.jcv.2014.02.002_bib0100","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1158\/1055-9965.EPI-10-1267","article-title":"Human papillomavirus (HPV) genotypes in women with cervical precancer and cancer at Kaiser Permanente Northern California","volume":"20","author":"Castle","year":"2011","journal-title":"Caner Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.jcv.2014.02.002_bib0105","doi-asserted-by":"crossref","first-page":"184e1","DOI":"10.1016\/j.ajog.2012.11.020","article-title":"Comparison of cervical cancer screening strategies incorporating different combinations of cytology, HPV testing, and genotyping for HPV16\/18, results from the ATHENA HPV study","volume":"208","author":"Cox","year":"2013","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jcv.2014.02.002_bib0110","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1002\/ijc.24528","article-title":"Multiple HPV genotype infections in cervical cancer progression in the study to understand cervical cancer early endpoints and determinants (SUCCEED)","volume":"125","author":"Wentzensen","year":"2009","journal-title":"Int. J Cancer"}],"container-title":["Journal of Clinical Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653214000663?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653214000663?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,6]],"date-time":"2018-10-06T13:26:05Z","timestamp":1538832365000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1386653214000663"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["S1386653214000663"],"URL":"https:\/\/doi.org\/10.1016\/j.jcv.2014.02.002","relation":{},"ISSN":["1386-6532"],"issn-type":[{"value":"1386-6532","type":"print"}],"subject":[],"published":{"date-parts":[[2014,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Individual detection of 14 high risk human papilloma virus genotypes by the PapType test for the prediction of high grade cervical lesions","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcv.2014.02.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}